Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Familial HypercholesterolemiaCholesterol, ElevatedGenetic Disease
Interventions
BEHAVIORAL

Motivational interview (MI)

"The MI intervention is adapted from the CHEERS study intervention (M Health Fairview) found to be effective in promoting lipid screening in patients at increased risk for FH.~Within one month of completion of the baseline survey, a study coordinator, who received training in motivational interview integrity, will conduct a 20-40-minute (depending on participant needs) telephone or virtual (zoom) interview with participants randomized to this arm. Participants will be assessed on their readiness to get their cholesterol checked and discuss with family members the risk of FH."

Trial Locations (2)

55805

RECRUITING

Aspirus St. Luke's Hospital, Duluth

RECRUITING

Essentia Health, Duluth

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Aspirus St. Luke's Hospital

UNKNOWN

collaborator

WHITESIDE Institute for Clinical Research

UNKNOWN

lead

Essentia Health

OTHER

NCT05238519 - Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH) | Biotech Hunter | Biotech Hunter